Li Xian, Qiu Pengfei, Yue Menglong, Zhang Ying, Lei Congshang, Wang Jingyu, Chen Xiwen, Qi Xuefeng
College of Veterinary Medicine, Northwest A&F University, Yangling, Shaanxi, China.
Key Laboratory of Ruminant Disease Prevention and Control (West), Ministry of Agriculture and Rural Affairs, Yangling, China.
Vet Res. 2025 Mar 7;56(1):52. doi: 10.1186/s13567-024-01428-1.
Finding suitable alternatives to antibiotics as feed additives is challenging for the livestock industry. Porcine beta-defensin 2 (PBD-2) is an endogenous antimicrobial peptide produced by pigs. Due to its broad-spectrum antibacterial activity against various microorganisms and its low tendency for drug resistance, it is considered a potential substitute for antibiotics. Additionally, given its strong ability to repair intestinal epithelial damage and maintain intestinal mucosal barrier function, porcine interleukin-22 (PIL-22) is a potential feed additive to combat intestinal damage caused by intestinal pathogens in piglets. In this study, the amino acid sequences of PBD-2 and PIL-22 were combined to express the fusion protein in Pichia pastoris, and its biological activity was evaluated in vitro. Our results showed that the PIL22-PBD-2 exhibits broad-spectrum antibacterial activity against multidrug-resistant enterotoxigenic Escherichia coli O8 (ETEC O8), Escherichia coli (E. coli), Salmonella typhimurium, and Staphylococcus aureus (S. aureus). PIL22-PBD-2 demonstrated wound repair capability through a healing assay in the intestinal porcine epithelial cell line-J2 (IPEC-J2). Furthermore, PIL22-PBD-2 significantly enhanced the expression of the major intercellular junction-associated proteins ZO-1 and E-cadherin in IPEC-J2. It is important to note that PIL22-PBD-2 reduced intestinal epithelial cell apoptosis (p < 0.05) considerably and decreased bacterial adhesion (p < 0.05) in ETEC O8-challenged IPEC-J2. We also found that the PIL22-PBD-2 treatment attenuated ETEC O8-induced inflammatory responses in IPEC-J2 by exerting antibacterial activity, increasing the expression of endogenous antimicrobial peptides, and significantly decreasing the mRNA expression levels of IL-6 and TNF-α (p < 0.05). In conclusion, our studies demonstrate that PIL22-PBD-2 has a positive effect on inhibiting pathogenic bacteria and repairing intestinal damage.
寻找抗生素的合适替代物作为饲料添加剂对畜牧业来说具有挑战性。猪β-防御素2(PBD-2)是猪产生的一种内源性抗菌肽。由于其对多种微生物具有广谱抗菌活性且耐药性低,它被认为是抗生素的潜在替代品。此外,鉴于猪白细胞介素-22(PIL-22)具有强大的修复肠道上皮损伤和维持肠道黏膜屏障功能的能力,它是一种潜在的饲料添加剂,可对抗仔猪肠道病原体引起的肠道损伤。在本研究中,将PBD-2和PIL-22的氨基酸序列进行组合,在毕赤酵母中表达融合蛋白,并在体外评估其生物学活性。我们的结果表明,PIL22-PBD-2对多重耐药产肠毒素大肠杆菌O8(ETEC O8)、大肠杆菌(E. coli)、鼠伤寒沙门氏菌和金黄色葡萄球菌(S. aureus)具有广谱抗菌活性。通过在猪肠道上皮细胞系-J2(IPEC-J2)中的愈合试验,PIL22-PBD-2展示出伤口修复能力。此外,PIL22-PBD-2显著增强了IPEC-J2中主要细胞间连接相关蛋白ZO-1和E-钙黏蛋白的表达。值得注意的是,PIL22-PBD-2在ETEC O8攻击的IPEC-J2中显著降低了肠道上皮细胞凋亡(p < 0.05)并减少了细菌黏附(p < 0.05)。我们还发现,PIL22-PBD-2处理通过发挥抗菌活性、增加内源性抗菌肽的表达以及显著降低IL-6和TNF-α的mRNA表达水平(p < 0.05),减轻了ETEC O8诱导的IPEC-J2中的炎症反应。总之,我们的研究表明,PIL22-PBD-2对抑制病原菌和修复肠道损伤具有积极作用。